Pera, N
Nature Medicine , 28(5), 898-910
[15] Highest completed human evidence: Phase 2, with the first Phase 3 obesity readout now reported
[9] Sermorelin (GRF 129) is even more transient, with a plasma half-life on the order of 1020 minutes in humans, limited by renal ultrafiltration and enzymatic degradation at the N-terminus
A 20 percent LDL reduction from a weight-loss-oriented triple agonist is therefore a genuinely new observation and helps explain why retatrutide is being developed across cardiovascular, metabolic, and weight-related indications rather than as a pure obesity asset
C-MET927-LZ c-MET (amino acids 1927) followed by a GGGGS linker, a GCN4 zipper sequence (RMKQL EDKVE ELLSK NYHLE NEVAR LKKLV GER), HR3C, Tsi3 tag, and His6 tag, was cloned into the pEZT-BM vector (Supplementary Table 1)